Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2014
07/10/2014US20140194475 Animal parasite-control method using insect growth regulators
07/10/2014US20140194474 Composition for treating atherosclerosis and a preparation method thereof
07/10/2014US20140194471 Substituted 1-benzylindolin-2-one analogs as positive allosteric modulators of muscarinic acetylcholine m1 receptors
07/10/2014US20140194468 Compounds that Suppress Cancer Cells and Exhibit Antitumor Activity
07/10/2014US20140194467 Plasma cell disorders
07/10/2014US20140194466 Perhexiline for use in the treatment of hypertrophic cardiomyopathy (hcm)
07/10/2014US20140194464 Crenolanib for Treating FLT3 Mutated Proliferative Disorders
07/10/2014US20140194461 Rapamycin formulations and methods of their use
07/10/2014US20140194460 Treatment of endometriosis
07/10/2014US20140194459 Method and composition for treating an alpha adrenoceptor-mediated condition
07/10/2014US20140194457 Carboxamide bioisosteres of opiates
07/10/2014US20140194456 Abuse-resistant controlled-release opioid dosage form
07/10/2014US20140194455 Oxidation-stabilized tamper-resistant dosage form
07/10/2014US20140194454 Combinations of trospium and salivary stimulants for the treatment of overactive bladder
07/10/2014US20140194453 Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
07/10/2014US20140194452 Pyrazolyl-Based Carboxamides II
07/10/2014US20140194450 Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide f2 alpha agonists
07/10/2014US20140194448 Transvaginal phosphodiesterase inhibitors for infertility treatment
07/10/2014US20140194443 Pyrazolyl-Based Carboxamides I
07/10/2014US20140194442 Anticancer therapy
07/10/2014US20140194439 Methods of targeted drug development
07/10/2014US20140194438 Compositions and methods for treating centrally mediated nausea and vomiting
07/10/2014US20140194432 Naphthyridinone derivatives and their use in the treatment, amelioration or prevention of a viral disease
07/10/2014US20140194431 Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
07/10/2014US20140194430 Substituted aminoimidazopyridazines
07/10/2014US20140194428 Combination treatments for bipolar disorders
07/10/2014US20140194427 Deuterium Substituted Fumarate Derivatives
07/10/2014US20140194423 Combination products
07/10/2014US20140194419 Chromenone derivatives
07/10/2014US20140194415 Fatty acid synthase inhibitors
07/10/2014US20140194410 Thiolactams and uses thereof
07/10/2014US20140194409 Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia
07/10/2014US20140194408 Heteroaryl pyridone and aza-pyridone compounds
07/10/2014US20140194406 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
07/10/2014US20140194401 Methods for reducing cellular proliferation and treating certain diseases
07/10/2014US20140194400 Nasal Pharmaceutical Formulation
07/10/2014US20140194399 Use of pufas for treating skin inflammation
07/10/2014US20140194398 Tanaproget Compositions Containing Ethinyl Estradiol
07/10/2014US20140194397 Multiple-component pharmaceutical formulations and methods for their use in treating neuropathology and neurodegeneration caused by traumatic injury
07/10/2014US20140194396 Organic compounds
07/10/2014US20140194395 Compositions and methods for treating centrally mediated nausea and vomiting
07/10/2014US20140194394 Two-component formulations, methods and procedures to prevent or reduce trauma-induced neuropathology and neurodegeneration
07/10/2014US20140194393 Tetracycline compositions
07/10/2014US20140194392 Drug screening method
07/10/2014US20140194391 Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
07/10/2014US20140194388 Combination therapy of hsp90 inhibitory compounds with chk inhibitors
07/10/2014US20140194385 Boronic acid derivatives and therapeutic uses thereof
07/10/2014US20140194384 Boronic acid derivatives and therapeutic uses thereof
07/10/2014US20140194382 Boronic acid derivatives and therapeutic uses thereof
07/10/2014US20140194381 Boronic acid derivatives and therapeutic uses thereof
07/10/2014US20140194380 Method of manufacturing composition comprising local anesthetic, heparinoid, and buffer
07/10/2014US20140194378 Methods of Preventing or Treating Diseases and Conditions Using Complex Carbohydrates
07/10/2014US20140194377 Salts of Isophosphoramide Mustard and Analogs Thereof
07/10/2014US20140194375 Topical antibiotic composition for the prevention of lyme disease
07/10/2014US20140194374 Anthelmintic Formulations and Treatments
07/10/2014US20140194373 Cosmetic use of hesperidin or a derivative thereof in the prevention and/or treatment of body odour
07/10/2014US20140194372 Heart failure suppressing agent
07/10/2014US20140194360 Use of antithrombin in extracorporeal membrane oxygenation
07/10/2014US20140194349 HIV Protease Inhibiting Compounds
07/10/2014US20140193534 Epicatechin for alleviating symptoms of allergy
07/10/2014US20140193533 Formulation of Curcuminoids with Enhanced Bioavailability of Curcumin, Demethoxycurcumin, Bisdemethoxycurcumin and method of preparation and uses thereof
07/10/2014US20140193532 Complementary Personal Lubricant Compositions
07/10/2014US20140193530 Pharmaceutical composition containing honeysuckle extract and antibiotics, pharmaceutical kit, and use of honeysuckle extract for preparation of drug
07/10/2014US20140193529 Modulation of Thymosin Beta-4 in Skin
07/10/2014US20140193528 Three-component formulations, methods and procedures, and combinations thereof, for reducing or preventing the development, or the risk of development, of neuropathology resulting from trauma
07/10/2014US20140193527 Formulations, methods and procedures for reducing or preventing the development, or the risk of development, of neuropathology as a result of trauma
07/10/2014US20140193526 Formulations, procedures, methods and combinations thereof for reducing or preventing the development, or the risk of development, of neuropathology as a result of trauma
07/10/2014US20140193523 Pharmaceutical formulations for the treatment and prevention of trauma-induced neuropathology and neurodegeneration
07/10/2014US20140193519 Indibulin therapy
07/10/2014US20140193510 Polymer-Agent Conjugates, Particles, Compositions, and Related Methods of Use
07/10/2014US20140193507 Preparation of injectable suspensions having improved injectability
07/10/2014US20140193504 Polymer-drug systems
07/10/2014US20140193501 Pulmonary Delivery in Treating Disorders of the Central Nervous System
07/10/2014US20140193498 Compositions and Methods for Treating Metabolic Disorders
07/10/2014US20140193497 Taste-masked pharmaceutical compositions containing diclofenac
07/10/2014US20140193495 Controlled release pharmaceutical compositions comprising a fumaric acid ester
07/10/2014US20140193494 Misuse preventative, controlled release formulation
07/10/2014US20140193493 Solid Dosage Forms of Oleyl Phosphocholine
07/10/2014US20140193492 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and crohn's disease
07/10/2014US20140193491 Pharmaceutical antiretroviral composition
07/10/2014US20140193490 Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
07/10/2014US20140193487 Compositions and methods for treating centrally mediated nausea and vomiting
07/10/2014US20140193481 Stabilised vaccine composition
07/10/2014US20140193480 Topical anti-inflammatory compositions and uses thereof
07/10/2014US20140193458 Method of vaccination comprising a histone deacetylase inhibitor
07/10/2014US20140193438 Enediyne compounds, conjugates thereof, and uses and methods therefor
07/10/2014US20140193436 Extracellular targeted drug conjugates
07/10/2014US20140193406 Methods used in identifying glioblastoma
07/10/2014US20140193398 Polymalic acid-based nanobiopolymer compositions
07/10/2014US20140193397 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
07/10/2014US20140193396 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
07/10/2014US20140193394 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum
07/10/2014US20140193393 Methods for Treatment of Stroke or Cerebrovascular Accidents Using an ETB Receptor Agonist
07/10/2014US20140193390 High Concentration Alpha-Glucosidase Compositions for the Treatment of Pompe Disease
07/10/2014US20140193379 Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
07/10/2014US20140193376 Combined chemical modification of sphingosine-1-phosphate (s1p) and cxcr4 signalling pathways for hematopoietic stem cell (hsc) mobilization and engraftment
07/10/2014US20140193371 Method for the Prevention and Treatment of Cancer, Tuberculosis and Related Diseases
07/10/2014US20140193370 Methods and compositions for promoting lean body mass growth
07/10/2014US20140193368 Pluripotent therapeutic compositions and uses thereof
07/10/2014US20140193365 Biodegradable Drug Delivery Composition
1 ... 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 ... 7860